Sign In
Buy DNLI
$19.66
+0.310 (+1.60%)
At Close: Jun 03, 2026
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
02:02pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Denali Therapeutics Inc. (DNLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen (BIIB) Inks Deal for Alectos' Parkinson's Disease Drug
12:51pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Biogen (BIIB) signs a deal with privately-held Alectos Therapeutics to gain an exclusive global license to the latter's pre-clinical oral selective GBA2 inhibitor, AL01811, targeting Parkinson's disea
Biogen (BIIB), Denali Begin Mid-Stage Study on Parkinson's Drug
01:00pm, Wednesday, 01'st Jun 2022 Zacks Investment Research
Biogen (BIIB) and partner Denali initiate a mid-stage study to evaluate their oral LRRK2 inhibitor, BIIB122, in adults with early-stage Parkinson's disease. A late-stage study is planned to start late
Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Tops Revenue Estimates
09:55pm, Thursday, 05'th May 2022 Zacks Investment Research
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -12.77% and 72.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the sto
Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Tops Revenue Estimates
07:34pm, Thursday, 05'th May 2022
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of -12.77% and 72.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the sto
AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Misses Revenue Estimates
12:35pm, Thursday, 05'th May 2022 Zacks Investment Research
AVEO (AVEO) delivered earnings and revenue surprises of -15.38% and 1.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
11:00am, Wednesday, 04'th May 2022 MarketWatch
The group rose at least 300% in the pandemic before crashing 70% or more.
Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
07:00pm, Monday, 25'th Apr 2022 Zacks Investment Research
Denali Therapeutics Inc. (DNLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
04:33pm, Monday, 25'th Apr 2022
Denali Therapeutics Inc. (DNLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Denali Therapeutics Inc. (DNLI) Up 7.4% Since Last Earnings Report: Can It Continue?
03:30pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
Denali Therapeutics Inc. (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
7 F-Rated Stocks to Avoid During the Downturn
03:10pm, Wednesday, 23'rd Mar 2022
It's easy to find hard hit stocks in this market, but what's harder to determine is which stocks are truly F-rated stocks among the losers. The post 7 F-Rated Stocks to Avoid During the Downturn appea
Denali Therapeutics Inc. (DNLI) Moves 7.5% Higher: Will This Strength Last?
05:41pm, Monday, 21'st Mar 2022 Zacks Investment Research
Denali Therapeutics Inc. (DNLI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be
Denali Therapeutics Inc. (DNLI) Moves 7.5% Higher: Will This Strength Last?
03:03pm, Monday, 21'st Mar 2022
Denali Therapeutics Inc. (DNLI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be
